Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 10, 2017
Piramal announced investments of $55 million across its sites in North America & Asia, to expand its API manufacturing capabilities and capacities.
read more
Piramal Critical Care announced the launch of MITIGO™ (Morphine Sulfate Injection, USP – Preservative-free) in 10 mg/mL and 25 mg/mL concentrations in the U.S. market.
read more
Thursday, November 17, 2022
Piramal Critical Care (PCC) has integrated its sustainability framework with its strategy as well as daily business practices.
read more
Tuesday, September 29, 2020
Piramal Pharma held a grand opening event at their recently acquired solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania.
read more
Tuesday, December 08, 2020
Piramal Pharma Limited has announced plans to expand its facility in Michigan with additional capacity and new capabilities for the development and manufacturing of APIs.
read more
Piramal has entered into an agreement with G&W Laboratories to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania.
read more
Piramal Pharma Ltd (PPL) announced the addition of three members to its board of directors. The company has added Mr. Peter Stevenson, Ms. Nathalie Leitch and Mr. Sridhar Gorthi to the board.
read more
Piramal Pharma Limited’s Pharma Solutions business, held a Grand Opening to celebrate the official inauguration of a new active pharmaceutical ingredient (API) plant at the company’s site in Aurora, Ontario.
read more
Tuesday, February 08, 2022
Piramal Pharma Limited's Pharma Solutions business announced the expansion of its Antibody-Drug Conjugate (ADC) capabilities at the Grangemouth facility in Scotland and the investment in new Active Pharmaceutical Ingredient (API) infrastructure at ...
read more
Tuesday, December 03, 2019
Piramal Enterprises Limited's Pharma Solutions business announced a partnership with BerGenBio on the development of bemcentinib for the treatment of elderly patients with relapsed AML.
read more
Piramal Pharma Limited's Pharma Solutions announced the appointment of Herve Berdou as Chief Operating Officer, Piramal Pharma Solutions (PPS).
read more
Tuesday, November 20, 2018
Piramal Pharma Solutions announced the completion of its new cGMP kilo lab suite at its API (Active Pharmaceutical Ingredient) site in Ennore, Chennai, India.
read more
Tuesday, January 28, 2020
Piramal Enterprises’ Pharma Solutions business announced plans to expand its Aurora facility in Canada with the addition of a new wing dedicated to manufacturing APIs.
read more
Piramal Pharma Limited’s Pharma Solutions business announced that the company’s site in Digwal in the state of Telangana, India, has implemented various tools to unlock Active Pharmaceutical Ingredient (API) manufacturing capacity and support client ...
read more
Piramal Pharma Limited's Pharma Solutions business announced that a new active pharmaceutical ingredient (API) plant at the company's site in Aurora, Ontario, has come online and successfully completed its initial production runs.
read more